Omar Shaltout: When Hematology Meets Gastroenterology in the ICU
Omar Shaltout, ICU Resident at Elkheer Hospital, shared on LinkedIn:
”When Hematology Meets Gastroenterology in the ICU:
A Catchy Case of Budd–Chiari Syndrome With Factor V Leiden Complicated by HRS
A 42-year-old female was admitted in a critical condition with progressive abdominal distension, hypotension, and worsening renal function.
Initial assessment showed a picture of advanced portal hypertension with tense ascites.
Ascitic fluid analysis revealed a high SAAG, confirming a portal hypertensive process.
Renal parameters were already deteriorating, raising early concern for hepatorenal physiology.
Imaging became the turning point.
Abdominal ultrasound and subsequent MRV confirmed acute thrombosis of all three hepatic veins, establishing the diagnosis of Budd–Chiari Syndrome.
The key clinical question was not the diagnosis itself, but the cause.
A comprehensive thrombophilia workup revealed a Factor V Leiden mutation (heterozygous), while secondary causes such as antiphospholipid syndrome and myeloproliferative disorders were excluded.
This finding explained the extensive hepatic venous thrombosis and reframed the case as a hematology-driven GI emergency.
Despite supportive management, the patient progressed into hepatorenal syndrome, with:
- Rapidly rising creatinine (peaking at 4.8 mg/dL)
- Severe hyponatremia
- Hypotension and metabolic derangement
Management became a delicate balance between:
- The need for lifelong anticoagulation due to inherited thrombophilia
- And the presence of significant liver-related coagulopathy and portal hypertension
This case highlighted how Budd–Chiari syndrome is never purely a hepatic disease.
It sits at the intersection of hematology, gastroenterology, nephrology, and critical care, where early recognition and timely escalation can be lifesaving.
Given the severity of portal hypertension and progressive HRS, urgent TIPS consideration with early liver transplant evaluation was recommended.”

Stay updated with Hemostasis Today.
-
Jan 23, 2026, 14:42David Stegner on PITTs Exacerbating Severe Inflammation
-
Jan 23, 2026, 14:30Christian Schulze: Time to Say Good-Bye to The “Obesity Paradox”?
-
Jan 23, 2026, 14:16Ahmed Nasreldein In The 1st Podcast Episode of International Journal of Stroke
-
Jan 23, 2026, 13:39Harshal Kale Invites You to WFH Webinar on World Health Assembly Resolution on Bleeding Disorders
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
